|6 Months Ended|
Dec. 31, 2019
|Derivative Instruments and Hedging Activities Disclosure [Abstract]|
The Company has issued common stock purchase warrants. Based on the terms of certain of these warrants the Company determined that the warrants were a derivative liability which is recognized at fair value at the date of the transaction and re-measured at fair value each reporting period with the changes in fair value recorded in the condensed consolidated interim statement of operations.
The derivative liabilities balance was zero at December 31, 2019 and June 30, 2019. The derivative liabilities balance consisted of the 2,180 agent warrants at December 31, 2019 and June 30, 2019.
The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef